Castle Biosciences and SciBase are advancing their work in the skin cancer market, with clinical studies entering the next phase and sales increasing.
1 report, 1 independent
Updated Aug 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Castle Biosciences and SciBase are advancing their work in the skin cancer market, with clinical studies entering the next phase and sales increasing.
How it developed
Newest first. Tap a step to see who reported it.- EIS, SciBase Holding AB, and Castle Biosciences established a collaboration in 2025 to utilize advanced EIS technology in their joint studies.Sub-event
Collaboration between Castle Biosciences and SciBase advances clinical studies and sales in the skin cancer market.1 source